A Stony Brook, New York resident, Dr. Elliott Bennett-Guerrero, is an alumnus of the Harvard Medical School, where he obtained a doctor of medicine. Dr. Elliott Bennett-Guerrero currently serves as the Medical Director for Perioperative Quality and Patient Safety for Stony Brook Medicine. He has led a few clinical studies dedicated to understanding the coronavirus disease.
In 2020, Stony Brook Medicine designed a clinical trial to aid the speedy recovery of patients from the coronavirus disease. In the first phase, Stony Brook Medicine gathered many convalescent plasma donations from Long Island residents who had tested positive for coronavirus in the past. The renowned healthcare facility hypothesized that the antibodies present in the convalescent plasma of former coronavirus patients could be useful to stop the infection of patients battling the virus. The clinical trial was randomized, and 80 percent of the participants were injected with convalescent plasma, while 20 percent were injected with standard plasma. The trial showed that convalescent plasma administration increased antibodies to the virus that causes COVID-19 (SARS-CoV-2) by 14.4% whereas standard plasma administration led to an 8.6% decrease (p=0.005) in these antibody levels. The study did not show an improvement in clinical outcomes such as time on the ventilator, although it may have been too small to show a small improvement.
0 Comments
|
AuthorDr. Elliott Bennett-Guerrero is both an educator and a vice chairman at Stony Brook Medicine. Archives
June 2022
Categories
All
|